From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Bristol-Myers Squibb Co.

www.bms.com

Most Recent Related Deals

BMS signs companion diagnostic deal with Saladax, 6/2010
BMS validates gene targets in SNALP deal with Tekmira, 5/2010
BMS grants exclusive US Lodosyn rights to Aton Pharma, 4/2010
Allergan sublicenses neuropathic pain agent to BMS, 3/2010
BMS signs two-year depression deal with NeurOp, 3/2010
BMS signs agreement with Tranzyme to develop macrocycles, 12/2009
BMS secures global rights to Alder's antibody ALD518, 11/2009
BMS conducts share exchange to split off Mead Johnson, 11/2009
DxS develops Erbitux companion test for BMS, ImClone, 9/2009
Sigma buys rights to 15 BMS drugs for $A60mm, 9/2009

Most Recent Related Articles

Click an article to see a free preview (15 of 1049).

Chronic Pain Indications Will Be Harder To Come By, FDA Says, The Pink Sheet 8/2010
Legal & Regulatory News, In Brief, The Pink Sheet 8/2010
Cardiovascular Outcomes Trials Increasingly Complicated By Missing Data, The Pink Sheet 8/2010
Earnings In Brief, The Pink Sheet 8/2010
Toprol-XL Eyed As Precedent For Brilinta Labeling On U.S. Efficacy Data, The Pink Sheet 8/2010
Brilinta Review Highlights Evidence Gap On Aspirin Dosing, The Pink Sheet 8/2010
Low-Dose Aspirin Label Could Pose High Commercial Hurdle For Brilinta, The Pink Sheet 8/2010
Wound Care: Finding a Niche, The Pink Sheet DAILY 8/2010
New Data Help Size Up Novel Class Of SGLT-2 Inhibitors In Diabetes, The Pink Sheet 7/2010
Tasigna Beats Sprycel To First-Line CML Punch, The Pink Sheet 7/2010
Biogen Makes Counterintuitive Move To Tap Exelixis's Scangos As CEO, The Pink Sheet 7/2010
Routine Gene Testing For Plavix Patients Unsupported By Evidence - ACC/AHA, The Gray Sheet 7/2010
Biogen Idec Taps Exelixis' Scangos To Be New CEO, Start-Up 7/2010
Celgene Moves Into Solid Tumors With $2.9 Billion Abraxis Acquisition , Start-Up 7/2010
Alzheimer's Start-Ups Face A Discovery And Clinical Crossroads , In Vivo 7/2010

See all 1049 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.